Platform
Features
0 followers
Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.
Industries
Headquarters
Stage
Employees
Links
Anil Singhal
2 members
3 members
GRAIL
27 followers
AbbVie
149 followers
Incyte
14 followers
ImmunityBio
2 followers
Adaptive Biotechnologies
11 followers
TG Therapeutics
1 follower
Cellares
Intercept Pharmaceuticals
Gilead Sciences
119 followers
Harvey
Regeneron
87 followers
Discover companies